ALTHOUGH there is no preventive vaccine or specific treatment at this time for the new coronavirus SARS COV-2, which causes COVID-19, the Cuban pharmaceutical industry is guaranteeing production of proven, high efficacy treatment medications, including recombinant human interferon alpha 2b, in addition to another group of drugs that are included in protocols for treating patients with this disease and the complications that may arise.According to the president of BioCubaFarma, Dr Eduardo Martínez Díaz, in this effort the company has taken into account the experience of China, via a guide pu